3 results match your criteria: "Biotherapy Institute for Rare Diseases[Affiliation]"

Atypical nuclear abnormalities in a patient with Brody disease.

Neuromuscul Disord

October 2015

Centre de Référence Maladies Neuromusculaires Nantes-Angers, CHU de Nantes, Nantes, France; Atlantic Gene Therapies - Biotherapy Institute for Rare Diseases, Nantes, France. Electronic address:

Brody disease was first described as a benign pseudo-myotonic disorder with muscular stiffness, which increased with exercise. Biochemical and genetic studies have pointed out its close relationship to a functional defect of the fast-twitch sarcoplasmic reticulum Ca(++) ATPase pump (SERCA1) encoded by the ATP2A1 gene located on chromosome 16. The histopathological features in this form of myopathy were generally described as non-specific, i.

View Article and Find Full Text PDF

Introduction: X-linked myopathy with excessive autophagy (XMEA) is an X-linked recessive myopathy due to recently reported mutations in the VMA21 gene.

Methods: Four men from 2 separate families were studied. The clinical presentation, genetic data, muscle biopsy, and muscle MRI were analyzed.

View Article and Find Full Text PDF

Clinical and electrophysiological features in a French family presenting with seipinopathy.

Neuromuscul Disord

February 2015

Centre de Référence Maladies Neuromusculaires Nantes - Angers, CHU de Nantes, Nantes, France; Atlantic Gene Therapy, Biotherapy Institute for Rare Diseases, Nantes, France.

Seipinopathies are a group of inherited diseases affecting upper and lower motor neurons due to mutations in the Berardinelli-Seip congenital lipodystrophy 2 gene (BSCL2). We report a French family carrying the N88S mutation in the BSCL2 gene. A 12-yr-old girl complained of bilateral asymmetrical pes cavus with right hand motor deficit and amyotrophy, asymmetrical leg amyotrophy and pyramidal signs.

View Article and Find Full Text PDF